What is Applied DNA Sciences Interest Expense?
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Applied DNA Sciences's interest expense for the
three
months ended in Mar. 2024 was $ 0.00 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Applied DNA Sciences's Operating Income for the
three
months ended in Mar. 2024 was $ -3.62 Mil. Applied DNA Sciences's Interest Expense for the
three
months ended in Mar. 2024 was $ 0.00 Mil.
GuruFocus does not calculate Applied DNA Sciences's interest coverage with the available data.
The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Applied DNA Sciences Interest Expense Calculation
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Applied DNA Sciences (NAS:APDN) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Applied DNA Sciences's Interest Expense for the
three
months ended in Mar. 2024 was $0.00 Mil. Its
Operating Income
for the
three
months ended in Mar. 2024 was $-3.62 Mil. And its Long-Term Debt & Capital Lease Obligation for the
three
months ended in Mar. 2024 was $0.47 Mil.
Applied DNA Sciences's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as
| GuruFocus does not calculate Applied DNA Sciences's interest coverage with the available data. |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Applied DNA Sciences Inc has enough cash to cover all of its debt. Its financial situation is stable.
Applied DNA Sciences (Applied DNA Sciences) Business Description
Traded in Other Exchanges
Address
50 Health Sciences Drive, Stony Brook, New York, NY, USA, 11790
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
Executives
| Clay Shorrock |
officer: Chief Legal Officer |
C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
| Scott L Anchin |
director |
16990 GOLDENTOP ROAD, SUITE A, SAN DIEGO CA 92127 |
| William W Montgomery |
10 percent owner |
34211 SEAVEY LOOP RD., EUGENE OR 97405 |
| Judith Murrah |
officer: Chief Information Officer |
C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
| Beth Jantzen |
officer: Chief Financial Officer |
C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
| Yacov A Shamash |
director |
|
| Robert B Catell |
director |
62 OSBORNE ROAD, GARDEN CITY NY 11530 |
| John Iii Bitzer |
director |
C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
| Joseph D. Ceccoli |
director |
C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
| Elizabeth M. Ferguson |
director |
50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
| Charles S. Ryan |
director |
C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
| James A Hayward |
director, officer: Chief Executive Officer |
C/O 25 HEALTH SCIENCES DRIVE, SUITE 113, NEW YORK NY 11790 |
| Karol Gray |
officer: Chief Financial Officer |
C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
| Ming-hwa Benjamin Liang |
officer: Strategic Tech. Dev. Officer |
C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
| Yacov Shamash |
director |
100 ENGINEERING, STATE UNIVERSITY OF NY, STONE BROOK NY 117942200 |
Applied DNA Sciences (Applied DNA Sciences) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
APDN has been successfully added to your 